Our Production Division encompasses the Hsinfeng Plant, Taichung Plant, Tainan Plants II and III, all of which are PIC/S GMP pharmaceutical manufacturing plants approved by the Department of Health in Taiwan, and Tainan Plant II also approved by the U.S. FDA,producing pharmaceuticals such as ordinary pharmaceutical cooling gels, sterile powders, Ampoules, Vials, SVP, LVP, liquids, ointments and suppositories, tablets, capsules, powders, penicillin antibiotics, and penicillin cooling gels for animals, cephalosporin sterile powder.
The Hsinfong Plant, Hsinfong Plant II and Taichung Plant have been accredited by Japan's PMDA, and products are being exported to the Japanese market.In 2014, expansion of the injection, solution and ointment lines at Tainan Plant I was completed, and the plant also passed the GMP inspection for veterinary drug plants. It is a specialized veterinary drug plant established based on the cGMP framework.
With years of endeavor through independent development, R&D partnerships, and technology introduction, CCPC now possesses special osmotic pump, repeated release, matrix, delayed release, and multiple layer device controlled release technologies and is capable of mass production of all types of pharmaceuticals and logistics management. It also has a top-end quality management system and R&D team. Besides being capable of researching and developing innovative products and producing high quality products, CCPC also provides import-license authorized development, registration, and contract R&D and production. For example, its contract manufacture clients include Takeda Pharmaceutical, Yamanouchi Pharmaceutical, Shionogi, Daiichi, Taiwan Sankyo Pharmaceutical, Ajinomoto, J&J, Roche, SORM, Try-X, and Impax (contract research).